Summary:
Summit Dermatology is conducting a prospective phase 2 study to test the safety and effectiveness of DPCP ointment in patients with warts.
Qualified Participants Must:
• Be between 18 and 65 years of age
•
Have warts for at least 4 weeks but no more than three years
•
Have warts located on hands, feet, limbs and/or trunk
Qualified Participants May Receive:
The study drug at no cost, physical exam, vital signs, lab/blood work and compensation for their time.